中文名称: | A-484954 | ||||
---|---|---|---|---|---|
英文名称: | A-484954 | ||||
别名: | 7-氨基-1-环丙基-3-乙基-2,4-二氧代吡啶并[2,3-d]嘧啶-6-羧酰胺;7-氨基-1-环丙基-3-乙基-2,4-二酮代吡啶并[2,3-d]嘧啶-6-甲酰胺 7-amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide | ||||
CAS No: | 142557-61-7 | 分子式: | C13H15N5O3 | 分子量: | 289.29 |
CAS No: | 142557-61-7 | ||||
分子式: | C13H15N5O3 | ||||
分子量: | 289.29 |
基本信息
产品编号: |
A11326 |
||||
产品名称: |
A-484954 |
||||
CAS: |
142557-61-7 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量 |
289.29 |
-20℃ |
1个月 |
||
化学名: |
7-amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
25 mg/mL (86.42mM; Need ultrasonic) |
|||
Ethanol |
|
||||
Water |
Insoluble |
||||
体内(现配现用): |
1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80 →45% saline Solubility: ≥ 2.5 mg/mL (8.64mM); Clear solution |
||||
此⽅案可获得 ≥ 2.5 mg/mL (8.64mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50 μ L Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
2.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility: ≥ 2 mg/mL (6.91mM); Clear solution |
|||||
此⽅案可获得 ≥ 2 mg/mL (6.91mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 20.0 mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。 |
|||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
3.4567mL |
17.2837mL |
34.5674mL |
5mM |
0.6913mL |
3.4567mL |
6.9135mL |
10mM |
0.3457mL |
1.7284mL |
3.4567mL |
生物活性
产品描述 |
一种真核延长因子 2 (eEF2) 的高度选择性抑制剂,其 IC50 值为 280nM |
靶点 |
IC50: 280nM (eEF2) |
体外研究 |
A-484954 is a highly selective eEF2K inhibitor with an IC50 value of 280 nM against eEF2K in the enzymatic assay and little activity against a wide panel of serine/threonine and tyrosine kinases. In enzymatic assay, the IC50 value of A-484954 is increased as the concentration of ATP increased but unaffected by increasing concentrations of calmodulin. |
体内研究 |
A484954 causes relaxation in E (+) and E (-) aorta or mesenteric artery precontracted with NA. Pretreatment with L-NAME but not indomethacin or cimetidine partially inhibits the A484954-induced relaxation in mesenteric artery. Long-term A484954 treatment inhibits MCT-induced increases PA pressure. It is revealed that A-484954 inhibits MCT-induced PA hypertrophy and fibrosis but not impairment of endothelium-dependent and -independent relaxation. Furthermore, A484954 inhibits MCT-induced NADPH oxidase-1 expression and ROS generation as well as matrix metalloproteinase-2 activation. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )